Literature DB >> 3494731

Epidermal growth factor receptor synthesis is stimulated by phorbol ester and epidermal growth factor. Evidence for a common mechanism.

J D Bjorge, J E Kudlow.   

Abstract

Previously, we and others have shown that epidermal growth factor (EGF) stimulates the synthesis of its own receptor and the accumulation of EGF receptor mRNA. Here, we demonstrate that the tumor promotor, 12-O-tetradecanoylphorbol-13-acetate (TPA), like EGF, also stimulates receptor synthesis in the human breast carcinoma cell line, MDA468 cells. The receptor synthesis rate increased 5-fold with a peak at 8 h after exposure to TPA with half-maximal stimulation at a dose of 5 ng/ml TPA. This stimulation of receptor synthesis occurred despite a 30% decrease in general cellular protein synthesis. The increased receptor synthesis rate resulted in the accumulation of 60% more receptor protein as determined by quantitative immunoblotting using a newly developed monoclonal antibody, H9B4. Although TPA treatment resulted in an immediate loss of high affinity EGF-binding sites, the long-term effect was an increase in both the low and high affinity binding sites. The effects of EGF and TPA on receptor synthesis were not additive. Furthermore, down-regulation of protein kinase C (the Ca2+/phospholipid-dependent enzyme) by long-term TPA treatment resulted in cells unable to respond to the stimulatory effects of both TPA and EGF on receptor synthesis. Nevertheless, the TPA-pretreated cells were still growth-inhibited by EGF. These results suggest that the stimulatory effect of EGF on receptor synthesis requires protein kinase C, whereas the inhibitory effect of EGF on the proliferation of these cells does not. Although we confirmed that EGF stimulated the incorporation of phosphate into phosphatidylinositol in A431 cells, it failed to do so in the MDA468 cells. Thus, in MDA468 cells, EGF may require protein kinase C for part of its action, but we could not demonstrate an associated activation of phosphatidylinositol turnover by EGF. The exact mechanism of involvement of protein kinase C in EGF action is still not clear.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494731

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Consumption of EGF by A431 cells: evidence for receptor recycling.

Authors:  H Masui; L Castro; J Mendelsohn
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

2.  Prolactin inhibits epidermal growth factor (EGF)-stimulated signaling events in mouse mammary epithelial cells by altering EGF receptor function.

Authors:  S E Fenton; L G Sheffield
Journal:  Mol Biol Cell       Date:  1993-08       Impact factor: 4.138

3.  Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide.

Authors:  V C Broudy; N Lin; J Egrie; C de Haën; T Weiss; T Papayannopoulou; J W Adamson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Activated type I phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation.

Authors:  J D Bjorge; T O Chan; M Antczak; H J Kung; D J Fujita
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 5.  EGF receptor expression, regulation, and function in breast cancer.

Authors:  S A Chrysogelos; R B Dickson
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

6.  Effects of cell density and phorbol esters on the expression of epidermal growth factor receptors.

Authors:  A Rizzino; C Huebert; C Kuszynski; P J Wilder
Journal:  Cytotechnology       Date:  1991-10       Impact factor: 2.058

7.  Tamoxifen inhibits transforming growth factor-alpha gene expression in human breast carcinoma samples treated with triiodothyronine.

Authors:  S J Conde; R A M Luvizotto; M T Síbio; M L H Katayama; M M Brentani; C R Nogueira
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

8.  Mechanisms of EGF receptor regulation in breast cancer cells.

Authors:  S A Chrysogelos; R I Yarden; A H Lauber; J M Murphy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Epidermal growth factor is synergistic with phorbol esters and vasopressin in stimulating arachidonate release and prostaglandin production in renal glomerular mesangial cells.

Authors:  B L Margolis; J V Bonventre; S G Kremer; J E Kudlow; K L Skorecki
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

10.  Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.

Authors:  Jeffrey D Bjorge; Andy S Pang; Melanie Funnell; Ke Yun Chen; Roman Diaz; Anthony M Magliocco; Donald J Fujita
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.